TOP STORIES
dermatology
Hair & nails

Hair growth achieved with novel formulation of JAK inhibitor


Sublingual tofacitinib may have a role in the management of alopecia areata with fewer side effects than the oral form of the JAK1/3 inhibitor. An Australian pilot study of sublingual tofacitinib was conducted  in 18 patients with moderate to severe,...

Sublingual tofacitinib may have a role in the management of alopecia areata with fewer side effects than the oral form...

Read more